Analysis Aurora hopes new CEO can stop the bleeding The once-promising producer previewed impairment charges of $1.8B, termination of UFC deal, while appointing Miguel Martin head boss Nick LabaSeptember 8, 2020
Analysis Rubicon Organics cuts down on losses in Q2 while investors bet big Its Simply Bare brand has been a hit with consumers, but can the firm translate quality product into profit? Yes, say analysts Nick LabaAugust 26, 2020
Canada Earnings week August: Pot stock feats and flops Quarterly reports from 10 cannabis companies paint two different pictures on either side of the US-Canada border Jared GnamAugust 17, 2020
CBD Cronos stock craters on weak Canadian weed sales and US$107M loss Cronos says its massive cash pile will help it execute its global cannabis strategy as Covid-19 pandemic derails its US CBD strategy Jared GnamAugust 7, 2020
Analysis WeedMD’s cash pile shrinks despite record revenues Outdoor-focused cultivator remains confident despite reporting cash position of only $14 million Jared GnamJuly 16, 2020
Analysis MediPharm watches revenues fall 65% Extractor also reports $12.8 million write-down due to glut of Canadian cannabis concentrates Jared GnamJune 18, 2020
Analysis Hexo says profits depend on more pot shop openings in Ontario, Quebec Shares of Hexo slipped another 5% after reporting a third-quarter net loss of $19.5 million Jared GnamJune 11, 2020
Cannabis 2.0 Canopy Growth shares sink after reporting another billion-dollar loss Company stock drops 20%, throws out previous profit targets for fiscal 2021 Jared GnamMay 29, 2020
Canada Aurora’s stock rallies on rising revenue The mega-producer's valuation rose almost 70% on the day but is still a far-cry from where many bought in Nick LabaMay 15, 2020
Canada Cronos continues to underwhelm in Q1, warns COVID-19 will hamper sales CEO Mike Gorenstein forecasts a 'bumpy' road ahead for Canada's weed industry Jared GnamMay 8, 2020